BPI-3016
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
COA:
Inquire
Targets:
Glucagon-Like Peptide 1 (GLP-1)
Description:
BPI-3016 is an analogue of human glucagon-like peptide 1 (hGLP-1) that has a long effect on type 2 diabetes mellitus. In vitro, BPI-3016 exhibited an affinity to GLP receptors and promotes cAMP production. In vivo, the half-life of BPI-3016 was 95h after single dosing in pharmacokinetic studies in diabetic cynomolgus monkey models.
Publictions citing BOC Sciences Products
  • >> More
Brife Description:
analogue of human glucagon-like peptide 1 (hGLP-1), type 2 diabetes mellitus
MSDS:
Inquire
Application:
the treatment of type 2 diabetes
Current Developer:
Betta Pharmaceuticals
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Glucagon-Like Peptide 1 (GLP-1) Products


CAS 910463-68-2 Semaglutide

Semaglutide
(CAS: 910463-68-2)

Semaglutide is an agonist of glucagon-like peptide-1 (GLP-1) receptor that is developed to treat type 2 diabetes. It reduces blood sugar via increasing the prod...

BPI-3016

BPI-3016 is an analogue of human glucagon-like peptide 1 (hGLP-1) that has a long effect on type 2 diabetes mellitus. In vitro, BPI-3016 exhibited an affinity t...

CAS 106612-94-6 GLP-1 (7-37) acetate

GLP-1 (7-37) acetate
(CAS: 106612-94-6)

GLP-1 (7-37) acetate is an insulinotropic peptide generated from the precursor peptide GLP-1(1-37). It is a potent stimulator of insulin secretion at concentrat...

CAS 141758-74-9 Exenatide

Exenatide
(CAS: 141758-74-9)

Exenatide, naturally occured in the saliva of the Gila monster, an incretin mimetic that has glucoregulatory effect. As a glucagon-like peptide-1 (GLP-1) recept...

Quick Inquiry

Verification code

Featured Items